Spur cell anemia is a hemolytic anemia seen in severe alcoholic cirrhosis that is characterized by unusual morphology and a decreased ratio of phospholipids to cholesterol in the erythrocyte membrane. We hypothesized that defective phospholipid repair may contribute to the red blood cell (RBC) phospholipid abnormalities of spur cell anemia. Therefore, we compared RBCs from normal control subjects with RBCs from spur cell anemia patients. The incorporation of ["C] arachidonic acid into the phospholipids and acylcarnitine (acyl-Cn) of spur cells and normal RBCs was analyzed by a direct-phase high performance liquid chromatography column to separate both the phospholipids and acyl-Cn.
PUR CELL ANEMIA is a hemolytic anemia of patients with severe liver disease, including alcoholic cirrhosis.' Spur cells have irregular cell surface projections, which are enlarged distally. Cooper et a12 showed that spur cell anemia red blood cells (RBCs) have excess membrane cholesterol and an increased ratio of cholesterol to phospholipid. Similar morphology is apparent in abetalipoproteinemia, but with only a mild compensated hemolytic p r o~e s s .~
To explain the extent of the morphologic and physical changes in vivo in spur cell RBCs, Cooper et a14 found it necessary to invoke splenic conditioning, because a patient with spur cell anemia showed a partial reversal of RBC morphology and hemolysis after splenectomy. One aspect of splenic conditioning is oxidative stress from the activated splenic macrophages. Evidence for oxidative stress in the RBCs of patients with alcoholic liver disease includes decreased linoleic acid (ciscis-9,12-octadecadienoic a~i d )~.~ and reduced glutathione (GSH). ' Although RBCs are incapable of lipid biosynthesis de novo, they are actively involved in phospholipid which is likely stimulated by lipid peroxidation.' Activated fatty acids may be stored by esterification to the hydroxyl group of carnitine (3-hydroxy-4-N-trimethylaminobutyric acid) as acylcarnitines (acyl-Cns). Acyl-Cns are potential metabolic intermediates in membrane phospholipid fatty acid turnover in RBCs before membrane phospholipid repair."," The Cn equilibrium reaction with acyl-Cn mediated by carnitine acyltransferases may buffer the equilibrium between coenzyme A (CoA) and acyl-coenzyme A (acyl-CoA). Ramsay and Arduini" propose that acylcarnitines serve as a store of activated acyl groups that are transferred to CoA as dictated by intracellular needs.
In this report, we present evidence in support of deranged phospholipid metabolism in spur cell anemia RBCs, namely, failure to show the expected increase (from the reticulocytosis) in total incorporation of fatty acids into RBC lipids, decreased fatty acid incorporation into phosphatidylethanolamine (PE), and increased incorporation into acyl-Cn. Measurement of acyl-Cn used a facile high performance liquid chromatography (HPLC) method.I3 In addition to previous evidence of abnormal RBC [voY~ol] ).'~ The collected fractions were identified by chromatography with known standards and analyzed by UV spectroscopy and phosphate analysis." Fatty acid composition was determined by gas-liquid chromatography." The HPLC fractions were monitored at 206 and 234 nm by UV spectrophotometers in series.
Enzyme assays. Acyl-CoA: 1 :palmitoyl-sn-glycero-3-phosphocholine acyl transferase was assayed using
[I4C] l-palmitoyl-lysophosphocholine and either palmitoyl-CoA or arachidonoyl-CoA as previously described."
Srurisrics. Statistical analysis used the software program True Epistat from Epistat Services (Richardson, TX). Results are expressed as means t standard error of the mean (SEM). Ninety-five percent confidence intervals (CI) are the mean 2 twice the SEM. In some experiments, one-tailed paired r-tests were performed because a specific null hypothesis was available.
RESULTS
We consistently observe a radioactive peak after labeling both normal and spur cell RBCs with radioactive fatty acids (palmitic, stearic, and arachidonic), with a retention time between 40 and 45 minutes on HPLC, just slightly after sphingomyelin.I6 Gas-liquid chromatography of this peak from RBC membranes after hydrolysis and derivatizationI8 showed a mixture of fatty acids similar in composition to normal RBC membrane phospholipid fatty acid composition. There was no corresponding increase in absorption at 206 or 234 nm. Phosphate analysis of this peak showed no detectable phosphate above background. Radioactive palmitic acid was largely used in subsequent identification because more palmitoyl derivatives were available commercially and this saturated fatty acid is reasonably stable. The radioactive peak isolated from labeled RBC membranes, although saponifiable, was resistant to pancreatic phospholipase, phospholipase C, and phospholipase A2. Unlike acyl-CoA, this peak was not converted to the acyl hydroxamate by neutral hydroxylamine, although it was susceptible to alkaline hydroxylamine. A review of likely acyl oxy-esters suggested that the peak was acyl-Cn. Cochromatography with standard palmitoylcarnitine reagent (Sigma) in a sufficient amount (0.459 pmol) to be observed at 206 nm overloaded and broadened both the radioactive and reagent peaks that were congruent. Although fatty acid precursors were not incorporated into sphingomyelin by RBCs, sphingomyelin was identified by its absorbance at 206 nm, with two peaks at 36 and 38 minutes, and cochromatography with known standards on HPLC and thin-layer chromatography. Palmitoyl-Cn has a slightly greater retention time (43 minutes) than arachidonoyl-Cn (41 to 42 minutes) but less than stearoyl-Cn (44 minutes). The acyl-Cn peak of membrane lipids from 0.375 mL of RBCs (the amount usually analyzed by HPLC) was not detected by the UV scan at 206 nm because of its negligible absorbancy, eg, the absorbancy of palmitoyl-Cn was found to be just 4% of equimolar PC.
We studied seven patients with alcoholic cirrhosis and severe spur cell anemia over a 3-year period. The characteristics of the patients are shown in Table 1 . Note the severity of the patients' liver disease in terms of the elevation of the prothrombin time, and the highly significant decrease in spur cell RBC GSH.
To control for the reticulocytosis of spur cell anemia patients, we studied the incorporation of fatty acids into reticulocyte-rich RBCs of three patients with blood loss anemia (5.6%, 7.4%, and 12.6% reticulocytes) and two patients with autoimmune hemolytic anemia (8% and 24% reticulocytes) compared with normal controls (1% to 2% reticulocytes We also measured conjugated dienes at 234 nm on the effluent from the HPLC column.'' Absorption at 234 nm was increased at 19 minutes of retention time in spur cell RBCs, but this proved to be a function of hyperbilirubinemia, because absorption at 19 minutes was also increased, proportional to the bilirubin, in RBCs from patients with obstructive jaundice but with no cirrhosis and no spur cells. Patients with obstructive jaundice showed no abnormality of fatty acid incorporation. Although there was decreased incorporation in the duplicate determinations of the phospholipids of the spur cell patient, more of the label was incorporated into neutral lipids, free fatty acids, and acyl-Cn. Table 2 shows the average of replicate determinations of incorporation of ['*C] arachidonate into 0.375 mL RBCs containing 48.6 +-0.7 pg lipid phosphorus from each of the seven patients studied during this period, as well as seven age-matched controls, with incorporation studies performed at the same time. Incorporation and percentage incorporation into PE and acyl-Cn are shown for patients and controls.
Also shown is the mean -+ SEM and the probability from a matched t-test with the null hypotheses that incorporation into PE is not decreased in spur cell anemia and that acylCn is not increased. Average total incorporation in spur cell RBCs (24,284 +-2,220 cpm) was not greater than control RBCs (28,786 2 4,097 cpm), as would be expected from the reticulocytosis. PE showed diminished incorporation in the spur cell RBCs when corrected for total radioactivity in the lipid extract and reported as a percentage. On the other hand, both cpm and percentage of the total counts of acylCn are increased in the RBC lipids of spur cell anemia patients to a highly significant extent. Counts in neutral lipids and free fatty acids were increased and counts in PC were decreased in spur cell patients, but the results were not statistically significant.
Decreased incorporation of fatty acids into PE and increased uptake into acyl-Cn does not appear to be confined to incorporation of arachidonate. Figure 3 shows the uptake of [I4C] palmitic acid into control and spur cell lipids. As with ['"C] arachidonate, there is decreased uptake in PE and increased uptake in Acyl-Cn. Note that the distribution of ['"C] palmitic acid is different than ['"C] arachidonic acid in both patients and controls, with a greater fraction of the palmitic acid label in the acyl-Cn, as has been previously observed."
To explore the possible role of oxidative stress in these results, we used a previously employed in vitro m0de1.l~ When normal RBCs were exposed to 100 pmoVL peracetic acid (4 hours at 25"C), GSH decreased to 1.3 pmoVg hemoglobin (CI, 0.9 to 1.7). With this same model, RBCs treated with 1 0 0 pmol/L peracetic acid (4 hours) and subsequently incubated with [I4C] arachidonate (20 hours) had decreased incorporation into both phospholipids and acyl-Cn; PE was 67% 2 7% of control, PC was 68% +-13% of control, and acyl-Cn was 71% t 9% of control. This model was not fully successful because, although phospholipid incorporation decreased as in spur cell RBCs, unlike spur cell RBCs, acylCn incorporation also decreased. A reasonable explanation may be that the increased acyl-Cn of spur cell anemia is, at least in part, a result of the reticulocytosis, obviously not present in the peracetic acid model. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Abbreviations: C, control; Pt. patient; P, probability.
Because uptake of both ["C] arachidonic and palmitic acids in spur cell anemia RBC lipids is decreased more into PE than PC, assay of the acyl-CoA lysoPE transferase would be most appropriate to explore possible explanations for the diminished uptake in PE. This has not been performed as yet because the radioactive substrate lysoPE is not available commercially. However, [I4C] lysoPC may be obtained, permitting study of repair of PC. In previous experiments, using aliquots of RBCs from the same individual, we showed inhibition of acyl-CoA lysoPC acyltransferase by peracetic acid." But, in spur cell anemia, we were unable to detect a significant difference in mean arachidonoyl-coenzyme A lysoPC acyltransferase (control, 4.33% ? 1.98% PC/mg membrane protein; spur cell, 3.94% ? 1.42% PC/mg). An analysis of variance showed that the large standard errors resulted from variations between individuals (both patients and controls) rather than in replicate determinations on the same individual. Our failure to observe a difference between patients and controls in acyltransferase activity may result from this individual variation, in addition to diminished intensity of oxidation compared with that in vitro from peracetic acid.I3 Palmitoyl-coenzyme A lysoPC acyltransferase likewise was no different in patients (control, 2.86% ? 0.36%/mg; spur cell, 2.62% +-0.49%/mg).
DISCUSSION
Although the observations presented here concerning changes in phospholipid metabolism do not show the mechanism of hemolysis in spur cell anemia, they do suggest at least three possible future lines of inquiry in this regard.
(1) Spur cells have been shown to have excess cholesterol compared with phospholipid, whereas target cells, with similar RBC cholesterol, have balanced amounts of phospholipid.' Spur cell anemia may result when RBC phospholipid biosynthesis is inhibited and unable to compensate for the added cholesterol, with the resulting imbalance producing decreased membrane fluidity and resulting in hemolysis.' (2) Loss of GSH sulfhydryls in spur cell anemia indicates a possible oxidative threat to enzyme thiol groups in enzymes and coenzymes as well as in membrane skeletal proteins. Because fatty acid acyl groups are activated, transported, and metabolized as their thioesters,' oxidation of thiol groups might modulate fatty acid metabolism. The mechanism of acyl-Cn increase remains to be determined. Because body Cn stores are in part dietary22 and malnourished cirrhotics are deficient in Cn,23 it is likely that the increased biosynthesis of acyl-Cn is not explained by acylation of excess stores of Cn. Because acyl-Cn labeling appears to be increased in presumably normal reticulocytes after blood loss or in autoimmune hemolytic anemia, the pattern of lipid incorporation in spur cell anemia RBCs may result from inhibition of uptake into PE (possibly oxidant-induced; cf, the effect of peracetic acid") and the increased uptake into acyl-Cn by reticulocytes. Oxidative inhibition of phospholipid repair is thus one possible pathophysiologic process. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From of hemolysis by producing membrane changes as a result of accumulation of this amphophile. Functional and morphologic abnormalities produced in vitro by incubating RBCs with 100 pmol/L palmitoylcarnitine have been notedz4 that, if present in spur cell anemia, could contribute to hemolysis by destabilizing the membrane.
In the past, most emphasis has been placed on exchange of lipids with the plasma by RBCs as an explanation of RBC abnormalities in spur cell anemia. However, for maintenance of the molecular species composition of RBC membranes, specific acylation of lysophospholipids by fatty acids activated as acyl-CoA must proceed normally. Acyl-Cn may be an integral link in this pathway. In this report, we present evidence of impaired phospholipid metabolism in spur cell anemia.
